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Abstract
Background: As suggested by the origin of the word, sphingolipids are mysterious molecules with various roles in
antagonistic cellular processes such as autophagy, apoptosis, proliferation and differentiation. Moreover, sphingolipids
have recently been recognized as important messengers in cellular signaling pathways. Notably, sphingolipid
metabolism disorders have been observed in various pathological conditions such as cancer and neurodegeneration.
Results: The existing formal models of sphingolipid metabolism focus mainly on de novo ceramide synthesis or are
limited to biochemical transformations of particular subspecies. Here, we propose the first comprehensive
computational model of sphingolipid metabolism in human tissue. Contrary to the previous approaches, we use a
model that reflects cell compartmentalization thereby highlighting the differences among individual organelles.
Conclusions: The model that we present here was validated using recently proposed methods of model analysis,
allowing to detect the most sensitive and experimentally non-identifiable parameters and determine the main
sources of model variance. Moreover, we demonstrate the usefulness of our model in the study of molecular
processes underlying Alzheimer’s disease, which are associated with sphingolipid metabolism.
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Background
Sphingolipids (SL) are a class of complex lipids with a sph-
ingoid base (Sph) [1]. Modifications of this basic structure
that consist in the addition of an amide-linked fatty acid
or phosphorylation lead to the formation of bioactive sph-
ingolipids such as ceramide (CER), ceramide-1-phosphate
(C1P), sphingosine-1-phosphate (S1P) or sphingomyelin
(SM) [2, 3]. Ceramide is a recognized branching point
in the metabolism of various sphingolipids subspecies.
There are three major pathways of ceramide synthe-
sis. In de novo synthesis pathway ceramide is created
from less complex molecules [4]. The second pathway is
the catabolism of complex sphingolipids, mainly sphin-
gomyelin [5]. Ceramides can also form through the break-
down of complex sphingolipids that are ultimately broken
down into sphingosine in the acidic environment of the
lysosome. In this pathway, known as salvage pathway, sph-
ingosine is then reused, it is reacetylated to form ceramide
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again [6]. At the same time, ceramide may serve as a sub-
strate in the synthesis of SM, C1P, and Sph which, in turn,
can be phosphorylated to S1P [7–11]. For a long time,
sphingolipids were believed to serve mainly structural
purposes and have only been recognized as important
messengers in cellular signaling pathways [12, 13] in the
last two decades.
A notable body of work has been devoted to studying
the influence of sphingolipid metabolism on cellular fate:
autophagy, apoptosis, proliferation or differentiation [14,
15]. Importantly, individual sphingolipid species appear
to have an antagonistic effect on cell growth and sur-
vival. The dynamic balance between proapoptotic (e.g.
CER and Sph) and antiapoptotic (prosurvival) molecules
(e.g. S1P and C1P) is termed sphingolipid rheostat [16].
Disruptions in themetabolic pathways involved in the reg-
ulation of this balance are believed to underlay various
diseases. Indeed, sphingolipids are known to have critical
implications for the pathogenesis and treatment of diverse
conditions such as cancer [17–20] and neurodegenerative
disorders (e.g. Alzheimer’s disease) [21–25].
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Related research
Formal modeling appears to be an excellent tool to predict
the response of a system to a wide range of both external
and internal factors in different scenarios. However, due
to the complexity of the sphingolipid metabolome and the
paucity of data, not much research has been performed
in the field of computational sphingolipidome modeling.
Only few models of SL metabolism are available in litera-
ture. The model provided by Vasquez et al. [26] refers to
de novo ceramide synthesis in yeast. It contains all essen-
tial elements of ceramide synthesis from nonsphingolipid
metabolism. However, no further steps involving the recy-
cling of ceramides and other more complex sphingolipids
(such as the SM catabolic pathway and salvage pathway)
are considered. The model proposed by Gupta et al. [27]
describes the C16-branch of sphingolipid metabolism in
RAW264.7 cells. An advantage of this model is that it
combines the lipidomics and transcriptomics data pro-
vided by the LIPID MAPS Consortium. However, the
model applied here is restricted to the closest metabolites
of C16 ceramide. None of the proposed models contain
cell compartmental division despite the fact that ceramide
metabolism is known to differ depending on the cell com-
partment such as the mitochondrion, the nucleus and the
cell membrane. Therefore, we found it appealing to cre-
ate a computational model for the metabolism of complex
sphingolipids in human tissues.
Our results
We propose a formal model of regulatory processes that
contain sphingolipid metabolism pathways. Computa-
tionalmodeling is based on ordinary differential equations
(ODEs) that describe the evolution of species concentra-
tion. The kinetics of our model is based on Mass Action
Law (MAL) for molecular transport reactions and the
Michaelis Menten (MM) approach for enzymatically cat-
alyzed reactions. The model also covers the potential
inhibitory effects of some species on the synthesis of other
species.
To the best of our knowledge, this is the first compu-
tational model of sphingolipid metabolism that includes
compartmentalization based on the typical structure of
a nondifferentiated eukaryotic cell. Reaction parameters
were estimated on the basis of publicly available litera-
ture data and some default assumptions based on expe-
rience with Biochemical Systems Theory [28], whereas
the initial concentrations of particular sphingolipd species
in each organelle were obtained from the LIPID MAPS
database [29]. To validate our model, we applied both
standard and novel methods of analysis, i.e. local sensitiv-
ity analysis [30], variance decomposition [31] and cluster-
ing of model parameters based on sensitivity indices [32].
Finally, we demonstrate the utility of our model to
study themolecular events underlying Alzheimer’s disease
(AD). The proposedmodel provides comprehensive, func-
tional integration of experimental data and will con-
tribute to the understanding of the interrelationships
between sphingolipid metabolism and various diseases
that remain elusive. Moreover, this is the first time that
two recently published methods of computational model
analysis (i.e. variance decomposition [31] and sensitiv-
ity clustering [32]) are applied in a medium-size realistic
biochemical model.
Results and discussion
Model of sphingolipid metabolism
Our model captures all essential elements of the complex
network of sphingolipid metabolism excluding de novo
ceramide synthesis which has been described by Vasquez
et al. [26]. It illustrates the general behavior of selected
subspecies in unspecified human tissue in nine subcel-
lular compartments. These compartments represent the
following organelles or their parts: the outer and inner
layer of the cell membrane, the cytoplasm, the endoplas-
mic reticulum, the cytoplasmatic and lumenal face of the
Golgi apparatus, the nucleus, the mitochondrion and the
lysosome. Our model includes 69 reactions of molecular
transport and biochemical transformation (Fig. 1).
Transport
We applied the Mass Action Law principle to describe
transport kinetics. Particular equations simulate different
transport pathways which are determined by the specific
biophysical properties of particular sphingolipids [33]. It
is worth highlighting that most of these molecules [i.e.
CER, SM and glycosphingolipids (GSL)] are restricted to
biological membranes. These can be transported between
organelles only in the form of complexes with lipid trans-
fer proteins [34], e.g. the CER transfer (CERT) protein
binds to CER. In addition, sphingolipids may change their
location in the form of vesicles, i.e. as an integral part
of biological membranes [35]. For example, the translo-
cation of SM and GSL from the Golgi apparatus to the
outer membrane is associated with exocytosis. Further-
more, SL may move into the lysosome when the endo-
cytosis complex is formed. SL species may also diffuse
along the membranes of interlinked organelles, as is the
case with ceramide that floats between the endoplasmic
reticulum and the nucleus [36]. On the other hand, Sph,
S1P and C1P are sufficiently hydrophilic to diffuse freely
from membranes to the cytosol, and similarly from the
outer membrane to the external environment [37]. How-
ever, it has been reported that the transport of C1P from
the Golgi apparatus to other cellular compartments may
also occur in associationwith specific transporter proteins
such as C1P transfer protein (CPTP) [38]. Water solu-
bility also determines a molecule’s ability to flip between












Fig. 1 The sphingolipid metabolism diagram. Network of the SL metabolism system. Diagram was generated in Matlab Simbiology software. The full model contains 69 reactions, 39 modeled species
and 37 reaction catalyzing enzymes. Oval boxes denote reacting molecule species, diamond boxes denote enzymes, circles denote reactions (small circles – transport, bigger circle metabolic reaction).
Solid lines connect reactants with reaction, short dash lines connecting diamonds to reactions denote enzymatic catalyzing influence. Long dash lines connecting ovals to reactions denote inhibition
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Sph is sufficiently amphipathic to move between mem-
brane layers [39, 40]. Finally, S1P requires specific lipid
transporters to traverse membranes [41, 42]. Complex
sphingolipids are unable to cross membranes without the
aid of specific flippases such as four-phosphate adaptor
protein 2 (FAPP2) which draws glucosylceramide from the
outer surface to the inner surface of Golgi cisterns [43].
Ceramide synthesis and degradation
The majority of reactions depicted in Fig. 1 are enzy-
matic. The Michaelis Menten model and simplified kinet-
ics were applied to describe different pathways of synthe-
sis and degradation of the selected SL species, including
ceramids. There are three major pathways of ceramide
synthesis. CER synthesis via de novo pathway is described
as the inflow of these molecules into the endoplasmic
reticulum. CER may also by generated through the acety-
lation of Sph. This reaction is catalyzed by different types
of ceramide synthases (CerS) [44] and is the final step of
the salvage pathway [6]. Notably, the endoplasmic Sph
metabolized in this pathway may be generated from the
degradation of S1P which is catalyzed by specific phos-
phatases (SPP1 and SPP2) [45] or from the lysosomal
degradation of complex SL species. This pathway is initi-
ated by acidic sphingomyelinase (aSMase) and is critical
to maintain proper concentrations of cellular SL [46, 47].
In addition to the abovementioned endoplasmic route
of CER synthesis, a similar subset of reactions occcurs
in the mitochondria. The reactions of mitochondrial SL
metabolism have not yet been completely understood. In
particular, enzyme specificity and the values of reaction
rate parameters are often unknown [48, 49].
The third route of CER synthesis is through the hydrol-
ysis of SM. The enzymes responsible for catalyzing these
reactions, sphingomyelinases (SMases) are classified into
three categories based on their optimum pH values and
subcellular distribution. The degradation of SM is essen-
tial for the homeostasis of cell membranes; it has also been
reported to be strongly associated with stress induced
apoptosis [14, 50, 51].
Finally, we describe CER hydrolysis. Ceramidases
CDase, seven of which have been described in humans,
catalyze the cleavage of fatty acids from CER which leads
to the production of Sph [52].
Synthesis of complex SL
The most complex SL are SM and GSL which are even
more diverse. Although some enzymes responsible for the
synthesis of these complex SL have been detected in e.g.
the nucleus, this pathway is mainly localized in the Golgi
apparatus. In both cases, the CER is used as a backbone
molecule. However, its conversion into either SM or GSL
depends on the transport pathway from the endoplas-
mic reticulum. A CER transported in the complex with a
CERT protein moves into the cis-Golgi where SM is gen-
erated in a reaction catalyzed by an SM synthase [53, 54].
On the other hand, CER must move into the trans-Golgi
via a vesicle-dependent pathway to form GSL in a series of
reactions [55].
S1P and C1Pmetabolism
Our model includes reactions of CER and Sph phos-
phorylation. The resulting S1P and C1P, unlike CER and
Sph, promote cell growth and have anti-apoptotic proper-
ties [16, 56]. The effect of these metabolites is regulated
by the activity of several enzymes: (i) ceramide kinase
(CERK) responsible for the synthesis of C1P in the Golgi
apparatus and the plasma membrane [57]; (ii) sphingosine
kinases (SK1 and SK2) which catalyze the phosphoryla-
tion of Sph in different subcellular locations [58, 59];
and (iii) phosphatases that hydrolyze S1P and C1P. Phos-
phatases include both lipid phosphate phosphatases of
broad specificity [Phosphatidic acid phosphatase types
2a (PAP2a), 2b (PAP2b) and 2c (PAP2c)] and S1P spe-
cific phosphatases (SPP1 and SPP2) [45, 60]. All of these
enzymes with their isoforms differ in substrate speci-
ficity, optimum pH values and subcellular localization.
Our model illustrates the majority of their known prop-
erties. For detailed characteristics see the reviewed arti-
cles [7–11]. It is worth highlighting that both S1P and
C1P have been identified as inhibitors of enzymes respon-
sible for CER synthesis, such as acidic sphingomyelinase
(aSMase) and serine palmitoyltransferase (SPT), the key
regulatory enzyme of de novo synthesis pathway. In our
model, inhibitory kinetics were used to describe this
inhibitory activity of S1P (see Additional file 1: Table S1).
Finally, our model includes the reaction of irreversible S1P
degradation. Catalyzed by sphingosine-1-phosphate lyase
(SPL1), this reaction of S1P hydrolysis to hexadecenal and
phosphoetanolamine allows to remove the sphingoid base
from the pool of SL metabolites [60, 61].
Model parameters
In conclusion, our model consists of 39 variables that
represent molecular species concentrations (some of
these are the same compounds but localized in dif-
ferent compartments, cf. Fig. 1). The metabolic reac-
tion network covers 69 biochemical reactions (enzymatic
and transport-related) between the reacting species. The
model is implemented in the form of a system of 69
ordinary differential equations (ODEs) that model the
dynamics of the reaction network. The 129 parameters of
inhibition and reaction rates in the stationary state that
represent the conditions of homeostasis constitute the rel-
evant input of the model and are presented in Additional
file 1: Table S1 while the 38 initial values of species
concentrations are presented in Additional file 1: Table
S2. To achieve conditions that resemble the intracellular
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environment during homoeostasis we stabilized species
concentrations to the stationary state of the system. The
initial values of lipid levels were obtained from the LIPID
MAPS [26]. In the following part of this article, the model
was validated by local sensitivity analysis, variance decom-
position and clustering analysis.
Computational validation of the model
Biochemical models are characterized by a substantially
larger number of parameters relative to size of avail-
able experimental data. Therefore, the exact estimation of
model parameters is highly difficult [62]. Thus, we used
mathematical modeling to analyze the interrelationships
between parameters and model dynamics. To verify the
assumptions of our model, several methods were applied
to obtain a broad view of the behavior of the modeled sys-
tem in normal and stress conditions. Validation methods
were based on recently proposed and classical approaches
that engage exact mathematical methods.
Local sensitivity analysis
For the outcome of the local sensitivity analysis [30] per-
formed for the system in stationary state homeostasis, see
Fig. 2 and Additional file 1: Figures S1-S3. The following
conclusions were drawn.
• The highest sensitivity indices among ceramide
species were assigned to mitochondrial and lysosomal
CER associated with the activity of ceramide synthase
(CerS) in the mitochondrion and sphingomielynase
(SMase) in the lysosome. The widest range of
sensitivity was observed for CER in the endoplasmic
reticulum, especially for the parameters of exogenous
CER inflow through the outer membrane and
endogenous CER via de novo synthesis in the
endoplasmic reticulum. Notably, CER in the
endoplasmic reticulum is also highly sensitive to the
parameters of reactions catalyzed by SMase in the
outer membrane. High sensitivity to the parameters
of exogenous inflow of CER and C1P show
membrane CER species, which are also sensitive to
the membrane reactions catalyzed by SMases (Fig. 2).
• For the sphingosine species, the greatest instability
behavior shows the mitochondrial Sph, that is highly
sensitive to the model’s inflows parameters as well as
the parameter of reaction catalyzed by the enzyme
CerS in the mitochondrion. Moreover, mitochondrial
Sph is sensitive to the SMase catalyzed reactions in
membrane (Additional file 1: Figure S1). In contrast,
concentration of Sph localized in cytosol is practically
invariant to parameters.
• Mitochondrial S1P shows the greatest instability
within the S1P species, not only for the model’s
inflows parameters and CerS in mitochondrion, but
also for parameters of reactions catalyzed by SMase in
membrane and lysosome. For the other S1P species,
the the mostly important is sphingosinokinase (SK) in
the reticulum, inner membrane and nucleus,
respectively. The cytoplasmic S1P is the most stable
S1P species (Additional file 1: Figure S2).
• Sphingomyelin in the outer membrane is the
dominant species within all other species;
consequently, the exogenous inflow of SM by outer
membrane is the most significant parameter for the
Fig. 2 The local sensitivity analysis of the CER species to the highly significant parameters
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SM species. This parameter does not play a
noticeable role for other species that are sensitive for
model’s inflows parameters by outer membrane
(exogenous: C1P, CER, Sph and S1P). Another
interesting feature is that the nuclear SM is the most
stable within SM species (Additional file 1: Figure S3).
Variance decomposition - homeostasis
The variance decomposition method enables to decom-
pose noise associated with uncertainty of the modeled
output into components related to different reactions
[31, 63]. The application of this method to our model
principally indicates the reactions corresponding to edges
in Fig. 1 incident to investigated species as the highest
noise generators. Nevertheless, some reactions were more
significant for investigated species than other incident
reactions, whereas for some other species, variances are
distributed equally among all reactions. To find the dis-
tinctive reactions, we calculated the mean variance for
each investigated species and set the threshold to 110%
of the mean variance. The results for CER species are
depicted in Fig. 3 and those for Sph, S1P and SM are
depicted in Additional file 1: Figures S4, S5 and S6,
respectively.
• Within the ceramide species, the highest variance
shows the mitochondrial and lysosomal CER. For
CER, the threshold set on 110% of average variance
was exceeded only by the reactions catalyzed by
ceramide synthase (CerS) and acid ceramidase
(ACDase) in mitochondrion. The membrane CER
species interact together; hence, for inner membrane
CER not only incident reactions exceeded the
threshold but also reaction incident with outer
Fig. 3 The variance decomposition of ceramide concentrations into components steaming from all model reactions. The red lines denote the
average variance components of the investigated species. The red bars denote the variance components that exceeded the threshold of 110% of
average. The x-axis denotes reactions numbers and y-axis denotes the size of variance components
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membrane CER catalyzed by aSMase. For the outer
membrane CER, the highest variance component
stems from the reactions incident with outer
membrane C1P and transport reaction of C1P from
Golgi apparatus to outer membrane. For the other
CER species the highest variance is caused by the
incident reactions.
• Within the sphingosine species, the highest variance
similarly to CER species falls to the mitochondrial
Sph, whereas contrary to the mitochondrial CER for
the mitochondrial Sph, all reactions’ noise
components are near to average. Interesting is that
two incident reactions connecting mitochondrial Sph
with mitochondrial CER exceeded threshold and two
other incident reactions connecting mitochondrial
Sph with mitochondrial S1P are significantly below
average. Similarly, nuclear and endoplasmic Sph have
high and almost equally distributed noise with most
significant incident reactions. For nuclear Sph the
threshold was exceeded also by reactions
non-incident with nuclear CER. For the membrane
Sph species, highly influential reaction was the Sph
membrane diffusion. For the inner membrane Sph
except the incident reactions, the high noise
components steams from reactions connected with
outer membrane CER (between outer membrane SM
and Sph). The outer membrane Sph significant
reactions include transport reaction of C1P from
Golgi apparatus to outer membrane and reactions
connected with outer membrane CER and outer
membrane S1P. For the lysosomal Sph, except
incident reactions, the high noise component steams
from reaction catalyzed by aSMase in lysosome. For
the cytoplasmic Sph except incident reactions the
threshold was exceeded by the reaction catalysed by Al
kaline Ceramidase (AlkCDase) in Golgi apparatus. For
Golgi apparatus Sph the noise was mainly
decomposed by incident reactions.
• The highest variability within S1P species has the
mitochondrial S1P; all its variance components
showed near to average noise and none of the
reactions exceeded the threshold of 110%. Variance
of all other S1P species steams principally from the
incident reactions with an exception of cytoplasmic
S1P, in which noise is generated mainly by lysosomal
reaction catalyzed by aSMases.
• The SM species have the highest noise among all
species and, contrary to most other species, the
variance of SM species steams almost equally from all
reactions.
Sensitivity-based parameter clustering (homeostasis)
Due to its complex structure, our model is perfectly
suited to test the applicability of the new method of
clustering mutually compensative parameters to detect
mutual relationships between them [32]. In general,
parameters sets are not pairwise independent and bio-
chemical models are often sensitive to linear combina-
tions of parameters, which makes them non-identifiable
[62, 64].
Through sensitivity clustering of parameters (see
Section Methods) we obtained a dendrogram where four
clusters may be clearly distinguished (Fig. 4). These clus-
ters may be interpreted as specific functional modules.
Our results are compatible with the theoretical compart-
ments recognized by Rao et al. [65], who presented the
sphingolipid metabolism pathway as a combination of the
following units: (i) the C1 compartment that represents
the de novo biosynthesis of CER, (ii) the C2 compartment
that reflects the conversion of CER into complex sphin-
golipids such as SM and GSL, (iii) the C3 compartment
that represents the hydrolysis of SM to CER and (iv) the
C4 compartment that reflects the conversion of CER into
bioactive molecules such as C1P and S1P.
Ceramide phosphorylation
In ourmodel, the brown cluster includes reaction parame-
ters from the endoplasmic reticulum, the Golgi apparatus,
the nucleus and the cytoplasm. The strong redundancy
among parameters reflects their functional correlation.
This cluster is primarily related to the conversion of Sph
to S1P and vice versa. Beyond sphingolipid phosphoryla-
tion and dephosphorylation, it also contains reactions of
sphingosine acetylation and CER deacetylation. This clus-
ter corresponds to the C4 compartment described by Rao
et al. [65] to some extent. However, our cluster fails to
include reactions that occur in the cell membrane; these
form part of the blue and green clusters. However, we
found the reaction that reflects the endogenous inflow
of ceramides into the endoplasmic reticulum (simulat-
ing the de novo synthesis pathway) to be a part of the
brown cluster. Notably, our analysis shows that reactions
in the endoplasmic reticulum are in functional unity with
nuclear reactions. This may be due to the fact that the
membranes of the reticulum are structurally linked with
the nuclear envelope.
Complex SL synthesis
The blue cluster contains reaction parameters associ-
ated with the molecular composition of the outer mem-
brane. Since the cell membrane is the biggest reservoir
of sphingolipids, particularly complex sphingolipids such
as sphingomyelin and glycosphingolipids, this cluster has
a strong influence on the overall balance of cellular sph-
ingolipids. The reactions from the pathway of CER pro-
duction via SM hydrolysis (which was mentioned above)
are localized in this cluster. This was confirmed by local
sensitivity analysis, the reaction catalyzed by aSMase in
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Fig. 4 a Dendrogram obtained by hierarchical clustering of parameters based on their functional redundancy. Identifiability analysis yielded 37
unidentifiable parameters (marked in red).The labels and corresponding names of parameters are provided in Additional file 1. b Clusters of reactions
induced by hierarchical grouping. The colors of connections between species are compatible with the colors of clusters in the dendrogram. Color
intensity within the cluster corresponds with the level of redundancy between reaction parameters and other parameters in the cluster
the outer membrane has a strong influence on the sta-
bility of several modeled species. As a consequence, the
pathways responsible for the synthesis of complex sphin-
golipids (SM and GSL) are localized in this cluster. These
reactions strongly affect the stability of endoplasmic CER
and subsequently, cytoplasmatic Sph. The blue cluster is
comparable to the C2 compartment as denoted by Rao
et al. [65] in that it reflects complex SL synthesis. How-
ever, extending the results given by Rao et al. [65], we
show that it is in functional unity with the reactions of
the outer cell membrane. It is worth highlighting that the
results of our simulations are consistent with literature
reports because SM metabolism in the plasma membrane
is known to have strong implications for the balance of
bioactive sphingolipids [66].
Sphingolipds degradation
The yellow cluster is related to the degradation of complex
sphingolipids in the acidic environment of the lysosome.
It includes the starting point of the salvage pathway, i.e.
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SM transport and degradation in the lysosome and, to
some extent, it resembles the C3 compartment described
in [65]. According to the local sensitivity analysis, two
reactions from this cluster that represent the transport
of SM from the outer membrane to the lysosome and
ceramide synthesis from SM in the lysosome may affect
the concentration of different molecular species in the
model, such as: the lysosomal and outer membrane CER,
SM and Sph, endoplasmic CER or mitochondrial S1P and
Sph. However, this influence is not very strong. This find-
ing may be explained by the relatively low activity of the
lysosomal degradation pathway in cells that develop in
favorable conditions. It should be mentioned that accord-
ing to the clustering analysis, the lysosome belongs to the
intersection of the yellow and blue clusters. This seems
biologically appropriate because this organelle links the
synthesis and degradation pathways of complex SL.
Innermembrane balance
The black cluster reflects the molecular balance of the
inner membrane and contains reaction parameters that
are not mutually related to other compartments, but have
a specific effect on the behavior of other pathways. For
instance, this cluster contains the reaction catalyzed by
nSMase in the inner membrane which, on the basis of
local sensitivity analysis, appears to slightly impact the
stability of CER, Sph and S1P in the entire model.
Application of themodel: case study of Alzheimer’s disease
Our model not only represents the functional integra-
tion of experimental data but may also be used for the
computational verification of molecular changes known
to cause various human diseases. In recent studies, it has
become evident that sphingolipids play important roles in
the trafficking and metabolism of AD - related proteins.
Thus, these are now acknowledged as crucial molecules
in the etiology of AD [23, 67]. This devastating neurode-
generative disorder is characterized by the accumulation
of intraneuronal and extracellular protein aggregates and
progressive synapse loss. The pathological hallmarks of
AD include the extracellular deposition of a peptide called
β-amyliod (Aβ), and neurofibrillary tangles. The inability
to catabolize aggregates of abnormally folded Aβ leads to
neuronal degeneration and a subsequent decline in cog-
nitive processes. On the level of sphingolipid metabolism,
the most frequently reported hallmarks of the disease are
ceramide accumulation in the endoplasmic reticulum and
lysosome, and sphingosine accumulation in the cytoplasm
accompanied by decreased levels of cytoplasmic S1P and
C1P [21–25].
Interestingly, Aβ has been reported to induce increase
in CER level through activation of nSMase, resulting in
nerve cell death. On the other hand, CER has been shown
to alter amyloid-precursor protein processing and Aβ
production. This mechanism was described as a CER
driven circulus vitiosus where increasing CER level leads
to an intensified Aβ production, whereuponAβ is respon-
sible for CER accumulation [24]. In this study, we applied
our model to determine whether changes in enzymatic
activity described by Rao et al. [65] lead to expected
changes in the concentration of observed SL species.
Currently our model allows to predict the fluctua-
tions in the concentrations of the sphingolipid species
and the activity of the enzymes involved in sphingolipid
metabolism. Such analysis could be useful to investi-
gate lipidomics aspect of development of various dis-
ease. Whereas present application of the model is limited
to analyze sphingolipid metabolism as a separate path-
way, we plan to integrate our model with genome-scale
metabolic network.
Computational simulation of Alzheimer’s disease
In an attempt to simulate the cellular response to
metabolic disturbances of the SL pathway described
in [65], the values of selected reaction parameters neces-
sary to achieve cell homoeostasis were changed. Detailed
information is provided in Additional file 1: Table S3.
We modified the parameters associated with ceramidase
(CDase) activity as well as the parameters corresponding
to the dynamics of sphingosine kinase (SK) and ceramide
kinase (CERK). Moreover, due to the down-regulation
of CERT expression we inhibited the transport of CER
to the Golgi apparatus. On the other hand, ceramide de
novo synthesis (represented by the inflow of CER into the
endoplasmic reticulum) was up-regulated. To test the sys-
tem’s response in an AD scenario we simulated the time
evolution of species concentrations.
Preliminary simulations showed that when changes
were limited to those described by Rao et al. [65], some
modeled species quickly diverged to infinity. Namely, we
observed an unexpected, rapid accumulation of SM in
several cellular compartments (i.e. the lysosome, outer
membrane and endoplasmic reticulum). Another unfore-
seen system behavior was an increased rate of CER to GSL
conversion in the Golgi apparatus, followed by the accu-
mulation of GSL. Since such events do not occur in AD
cells, we suggested that the initially introduced modifi-
cations should be accompanied by: (i) reduced transport
of CER to the Golgi apparatus via a CERT independent
pathway, and (ii) increased activity of sphingomyelinases
(SMase). We also introduced some minor changes in SM
transport between compartments. Our predictions were
confirmed by literature reports whereby impaired SM
metabolism is known to be linked with AD [68, 69]. These
findings emphasize the predictive value of our model.
Once these biologically justified modifications were
made, our results were coherent with experimental data:
we observed the accumulation of ceramides in cellular
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Fig. 5 Time evolution of molar concentrations of the following species (the dashed lines correspond to the homeostasis scenario and solid lines to
the AD scenario): (a) ceramide species; (b) sphingosine species; (c) sphingosine-1-phosphate species; (d) species functionally related to AD
compartments, particularly in the endoplasmic reticulum
(ER) and lysosome relative to homoeostasis levels [65, 67].
As far as the concentration of Sph species in the model
output is concerned, an immediate decline was observed
due to CDase down-regulation. This was followed by the
accumulation of Sph species in all compartments due to
increased concentrations of CER species, the substrates
for Sph synthesis. We also observed decreased concentra-
tions of S1P species in the AD scenario (Fig. 5).
Local sensitivity analysis: AD scenario vs. homeostasis
Application of the AD scenario yielded slight changes in
local sensitivity parameters.
• For the CER species, in contrary to homoeostasis, the
most sensitive become ceramides in nucleus and
endoplasmic reticulum, which are sensitive basically
to endogenous CER in endoplasmic reticulum and
exogenous C1P, CER, Sph and S1P in outer
membrane inflow parameters as well as nSMase
reaction rate in outer membrane.
• The S1P in cytosol becomes sensitive to the SK2 in
cytosol , analogously S1P in inner membrane
becomes sensitive to SK1 in inner membrane and S1P
in outer membrane is more sensitive to inflow
parameter of exogenous S1P in outer membrane.
However, the mitochondrial S1P becomes invariant
to parameters changes.
• Sph species remains largely unchanged with most
sensitive mitochondrial S1P.
• Similarly SM species show an unchanged sensitivity
with the dominant species SM in outer membrane as
most sensitive.
Parameter clustering: AD scenario vs. homeostasis
Clustering analysis of AD model resulted in new parame-
ter dendrogram, with only two clusters in comparison to
four clusters obtained in homoeostasis (Fig. 6 vs Fig. 4).
Clusters distinguished in AD simulation can be described
as follows.
Complex sphingolipidmetabolism
Parameters that are strongly associated with the
metabolism of complex sphingolipids and glycosphin-
golipids were included in the green cluster. Our results
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Fig. 6 a Dendrogram obtained for AD scenario by hierarchical clustering of parameters based on their functional redundancy. Model contains 36
non-identifiable parameters. b Clusters of reactions induced by the hierarchical grouping
show that changes in SM balance are of great importance
for cellular metabolism in AD. This cluster includes
ceramide formation via SM hydrolysis, and the catabolism
of SM and GSL in the lysosome (salvage pathway). Simi-
larly to the results obtained for the state of homoeostasis,
simulations in the AD scenario confirm that the hydrol-
ysis of SM in the cell membrane and lysosome strongly
influence the level of cytoplasmic Sph. This cluster also
includes the parameters related to the synthesis of GSL
and SM in the Golgi apparatus. To conclude, this cluster
can be viewed as a combination of the green, yellow and
part of the blue homeostatic clusters and is formed as a
result of increased SM transport and degradation during
neurodegeneration.
Ceramide synthesis and accumulation
The red cluster includes reactions affected by the
inflow of ceramides from the de novo synthesis path-
way. According to [70], the endoplasmic accumulation of
ceramides from this source is an important step in AD
development. Clustering analysis confirmed a strong cor-
relation between de novo synthesis and concentration of
CER in the endoplasmic reticulum and subsequently in
the mitochondrion, nucleus and Golgi apparatus.
Predictive power of the model
In this section we explore the issue of experimental vali-
dation of our model. We decided to propose first compre-
hensive model of sphingolipid metabolism in unspecified
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human tissue being aware of the scarcity of experimen-
tal data. Previous models were based on yeast and mouse
datasets and were more specific, see e.g. [27] that models
the C16-branch of sphingolipid metabolism in RAW264.7
cells. On the other hand most datasets for human sam-
ples come from mass spectrometric analyses of complex
body fluids [71]. Such lipidomics data would be of crucial
importance while studying the secretion of SL species to
these fluids. However for this kind of analysis the intra-
cellular model should be designed first. We would like to
emphasize, that almost all model parameters were based
on experimental measurements. Particularly the rates for
transport reactions were estimated according to experi-
mental data stored in LIPID MAPS database.
Summarizing, the predictive power of our model can be
assessed only in a qualitative way, as there are no experi-
mental data available to whose it can be fitted. Therefore
we argue, that the computational analysis that reproduces
the outcomes from [65] at the moment is the only method
available to verify the suitability of the model. Of course,
the experimental validation of model predictions would
be a subject of follow up research. Currently our collab-
orators from Mossakowski Medical Institute PAS carry
out experiments on SH-SY5Y cell lines and we hope that
obtained data would be useful to evaluate the predictive
power of our model.
Conclusions
In the present study, an original model for sphingolipid
metabolism in non-specified human tissue was proposed.
To the best of our knowledge, this is the most compre-
hensive model thus far and also the first to explicitly com-
prise compartmentalization. What is important, we have
managed to achieve balance between the complexity and
biological soundness of the model and its computational
tractability.
Our results demonstrate that this model is an excellent
tool to predict the response of the SL pathway to per-
turbations in the activity of particular enzymes as well as
the up- or downregulation of the modeled species. There-
fore, the model is perfectly suited to simulate molecular
behavior in various scenarios as in this case study of AD.
Moreover, the implementation of semi-independent
compartments allows more subtle manipulations of the
reaction parameters for specific organelles. Finally, our
model enables not only the integration but also validation
of experimental data by verifying their cross-compliance
in a complex network of interactions.
In addition, the computational validation of the model
was performed using recently proposed, sophisticated
approaches [31, 32]. Mathematically elegant methods
of variance decomposition and sensitivity clustering
of parameters revealed non-trivial biological outcomes.
Furthermore, the application of the abovementioned
approaches in our model served as the perfect validation
of their usefulness in realistic size problems.
Methods
All molecular reactions within a system of interact-
ing species S1 . . . SN may be presented in the following
manner:
Rj : ν1jS1 + · · · + νNjSN
kj−→ ν1jS1 + · · · + νNjSN ,
where νnj and νnj denote amounts of molecules of n-
th species that are respectively substrate and product of
this reaction and the coefficient kj denotes reaction rate
(speed) of the reaction.
TheMass Action Law kinetics
In case of non-enzymatic transport kinetics we used the
Mass Action Law (MAL) principle. The time derivative of
each species concentration is the sum of in- and out-fluxes
of all neighboring reactions. Here the one reaction flux is
equal kj [S1]ν1j · · · · · [SN ]νNj . Hence, ODEs derived from





snjkj [S1]ν1j · · · · · [SN ]νNj n = 1 . . .N
where snj = νnj − νnj denotes a stoichiometric coeffi-
cient of n-th species in j-th reaction and [ Sn] denotes the
concentration of n-th species.
TheMichaelis Menten kinetics
Majority of the reactions depicted in the diagram 1 are
enzymatic reactions. For this kind of reactions we used
Michaelis Menten model (MM) and simplified kinetics





where P denotes reaction product, S denotes reaction
substrate and Vmax, Km are constant reaction parameters.
Ordinary differential equations




where the system state is represented by the time depen-
dent state vector S(t) of species concentration,M denotes
the stoichiometry matrix and v(S(t)) denotes a vector of
reaction fluxes (in our model, according to MAL or MM
kinetics including inhibition rates) [30].
Local sensitivity analysis
Local sensitivity analysis shows how the uncertainty of
parameters of the model can influence the model out-
put. Sensitivity may be measured by monitoring changes
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in the output by e.g. partial derivatives of the modeled
species to the single parameters. This appears to be a log-
ical approach because any change observed in the output
will unambiguously be due to the single variable changed.
To compare the sensitivity of the model to the single
parameters we constructed the sensitivity indices by time








where Sn are different species concentrations, θ is the vec-
tor of parameters and θ0 is some fixed point in parameters
space.
Variance decomposition
The deterministic approach that represents the mean
behavior of the system can also be generalized to a
stochastic mode by meaning of Stochastic Differential
Equations (SDE), both of which can be represented in a
discrete Markov Chain or a continuous Markov Process.
Below we sketch themethod of variance decomposition as
presented by Komorowski et al. [31].
Stochastic differential equations
Modeling the system behavior in a stochastic manner
means the examination of not only the evolution of the
average system state that represents a possible trajec-
tory, but examination of the evolution of the probability
distribution over all possible system states.
The most popular approach to describe discrete
stochastic model of biochemical pathway is Chemi-
cal Master Equation (Chapman-Kolmogorov equation of









where the system state is denoted by the vectorX(t) ∈ NN
of numbers of molecules each row for one of N react-
ing species, mj denotes the j-th column of stoichiometry
matrix M = (m1, . . . ,mR) and P(x, t) denotes the time-
and state-dependent distribution of system being in state
X(t) = x and finally aj(X(t)) denotes the propensity
function associated with the j-th reaction [30].
One of the possible simplifications of the above equation
is Linear Noise Approximation, where the dynamic is
modeled with Poisson process:











where Nj(X(t), t) denotes Poisson process dependent on
time and a system stateX(t), corresponding to occurrence
of j-th reaction. The probability that j-th reaction occur
during the time interval [ t; t + dt) equals fj(x, t)dt, where
the fj(x, t) is called the transition rate.
Although accurate discrete models describe the exact
evolution of probability distribution of the system with
the assumption that in one time point at most one reac-
tion can occur, they are computational not efficient, as
simulations require significant resources. Consequently,
it is more efficient to transit from discrete to continuous
process. Starting from deterministic approximation:







where (t) is the mean system state being the solution of
the ODEs that can describe the system state evolution by
dividing it into deterministic and stochastic part:
x(t) = ξ(t) + (t)
where (t) is the deterministic part and ξ(t) is the Winer
process describing stochastic noise of a system state [72].
The next step of stochastic noise decomposition is to
divided noise linearly into noise steaming from separate
reactions. The fact, that the total variance:
	(t) = 〈(x(t) − 〈x(t)〉)(x(t) − 〈x(t)〉)T 〉
is described by the differential equation
d	
dt = A(t)	 + 	A(t)








and D(t) denotes diffusion matrix, can be represented as
the sum of individual contributions,
	(t) = 	(1)(t) + . . . + 	(r)(t). (2)
results directly from the decomposition of the diffusion
matrix D(t) = ∑rj=1 D(j)(t) and the linearity of the
equation for	(t). Komorowski et al. [31] By decomposing
variance into the components from individual reactions,
we are able to determine the variability that the model has
from each reaction, and therefore we are able to assess and
weigh the uncertainty of the model in division into single
reactions.
Parameter clustering
Nienałtowski et al. [32] proposed the concept of func-
tional redundancy and used it as a dissimilarity measure
in a hierarchical clustering algorithm. Let us define the
model in Bayesian approach by the distribution of data
(X ∈ Rk) given parameters (θ ∈ Rl) as P(X|θ), together
with a priori distribution P(θ). Let us assume that θ =
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(θA, θB) corresponds to the division of parameters in two
independent sets, then [73]:
H(X) = I(X, θA) + I(X, θB) + I(θA, θB|X) + H(X|θ),
(3)
where H denotes here the entropy and I is the mutual
information between random variables. Here, I(θA, θB|X)
measures the part of entropy that is shared by both sets of
parameters and is equivalent to redundant knowledge of
the model, which is owned by θA and θB.
The computation of I(θA, θB|X) requires calculation
integral over all possible outcomes of the model, which is
highly inefficient; hence, this notion was replaced with the
local redundancy measure, which substitute assumption
of knowledge regarding the model X with information
regarding initial parameters θ∗. Thus, functional redun-
dancy is equal to I(θA, θB|θ∗) and is calculated according
to a given formula [74]:
I(θA, θB|θ∗) = −12
min(|θA|,|θB|)∑
i=1
log(1 − ρ2j ), (4)
where ρi stands for the canonical correlation obtained
from the Fisher information matrix of θ∗ (FIM(θ∗)).
Moreover, to indicate non-identifiable parameters, the
authors defined (δ, ζ ) - identifiability using the idea of
functional redundancy [32]. In this terminology, θi is (δ, ζ )
– identifiable if FIMii(θ) > ζ and ρ(θi, θ−i) < 1−δ, where
θ−i represents all parameters except θi.
Using functional redundancy, we can cluster parameters
according to a hierarchical algorithm (i.e. in every turn of
the loop we merge two sets of parameters with the biggest
redundancy measure and remove all non-indentifiable
parameters from further analysis) and visualize it on a
dendrogram.
Note
SMBL file with the model implementation of homoeosta-
sis and model implementation of AD are provided as
Additional file 2 and Additional file 3.
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Additional file 2: SMBL file with the model implementation of
homoeostasis.
Additional file 3: SMBL file with the model implementation of AD.
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